Skip to content

Nephrotic Syndrome Type 4 C3151568

Published: July 22, 2026Updated: August 20, 2026

A genetic kidney disorder causing excessive protein in urine and swelling. It primarily affects children and is managed with medications to control symptoms and slow progression.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q63.9
ICD-11
LA00.0
Body system
renal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pulmonary edema (fluid overload)

Changes in urination or swelling

(renal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Persistent heavy proteinuria

(renal)

Bilateral lower‑extremity pitting edema

(renal)

Hypertriglyceridemia (elevated triglycerides)

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunosuppressive combination therapy

Cyclophosphamide or mycophenolate may be combined with corticosteroids for steroid-resistant cases. Treatment selection considers disease severity and patient factors.

medication
2

Renal disease management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Corticosteroid therapy

Initial corticosteroid therapy aims to achieve remission of proteinuria. taper based on response and tolerance.

medication

Additional treatment options

Edema management

Elevation of affected limbs and compression therapy may complement pharmacological diuretic therapy for symptomatic edema relief.

lifestyle

Anticoagulation assessment

Evaluation for thrombotic risk with consideration of prophylactic anticoagulation given increased hypercoagulability in nephrotic states.

medication

Vaccination review

Ensure pneumococcal and other appropriate vaccinations given increased infection susceptibility. Live vaccines contraindicated during immunosuppression.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Nephrotic Syndrome Type 4 C3151568?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Nephrotic Syndrome Type 4 C3151568. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy